Skip to main content
Premium Trial:

Request an Annual Quote

Protein Forest, PBI Ink Co-Marketing, R&D Deal

NEW YORK (GenomeWeb News) – Pressure BioSciences and Protein Forest have struck a research and development and co-marketing agreement that will combine their proteomics software and protein enhancement and extraction products, the companies said today.

The companies have agreed to work together to develop new instruments, modules for existing ones, and consumables that combine Protein Forest's software and fractionation products with PBI's extraction and digestion enhancement products.

The companies will co-market their product lines in industry publications, at scientific meetings, on the web, at trade shows, and through collaborator studies.

The companies said that a combination of their respective technology platforms will provide an integrated workflow for handling sample preparation issues that come up in mass spectrometry research labs.

PBI President and CEO Richard Schumacher said in a statement that the alliance "will greatly facilitate the introduction of our respective product lines to the mass spectrometry market, but without the need to increase sales staff, marketing budgets, and time at scientific meetings. We believe this is a very cost-effective way to significantly increase market penetration."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.